5 Amendments of Marian HARKIN related to 2010/2153(INI)
Amendment 10 #
Motion for a resolution
Recital A
Recital A
A. whereas the national and international health authorities, including the WHO, were aware as early as May 2009 that the H1N1 influenza was nothad rapidly lost its initial high virulentce, with this moderate virulence being confirmed by the very low mortality rate observed as a result of this influenza ‘pandemic’ in comparison with the officially recognised figures for seasonal influenza,
Amendment 20 #
Motion for a resolution
Recital B
Recital B
B. whereas the criteria for defining a ‘pandemic’, adopted by the WHO in 2009 and based solely on the propagationtransmission capacity of the virus while discounting the severity of the infection, distorted the meaning of the word ‘pandemic’ and triggered a false alarm worldwide, with that alarmism giving rise to inappropriate public health decisions and a disproportionate response among the public and administrations of the European Union and its Member States,
Amendment 120 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. That the ECDC be requested to assemble an expert and independent group of scientists and health care professionals are tasked with providing advice on non-pharmaceutical approaches that might be employed by Member States and the public to reduce the risk of infection or transmission and the severity of symptoms associated with infection;
Amendment 166 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Expresses its approval of the introduction of a procedure enabling the Member States to make group purchases of anti-viral vaccines and medicinal products on a voluntary basis where the positive benefit-risk profile of their preventive/therapeutic effect is clearly demonstrated and indisputaindependently, conclusively and plausibley, in order to obtain, for a given product, advantageous rates approaching its cost price;
Amendment 169 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Requests the development and release of an independent and comprehensive public health strategy including non-pharmaceutical approaches for the prevention and management of infectious diseases, including those caused by influenza viruses, in order to assist European citizens, health care professionals and health authorities in Member States;